Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP) -- Ignore unavailable to you. Want to Upgrade?

To: Sean Janzen who wrote (1331)	11/16/1999 8:29:00 PM
From: Chuca Marsh	Read Replies (1) \| Respond to of 1501

Here goes: Inflazyme Pharmaceuticals Ltd - Fagan says keep an eye on Inflazyme Inflazyme Pharmaceuticals Ltd IZP Shares issued 44,379,628 1999-11-12 close $1.16 Monday Nov 15 1999 Brian Fagan, writing in Interim Market Report No. 25 (Nov. 9), says Inflazyme Pharmaceuticals is a hold at $1.10 -- and a buy if it reaches $1. "If it continues to drop in price, it will be a screaming Buy," he writes. Mr. Fagan recommended the stock in July, 1998, at 86 cents. At the time, he liked its working capital position ($8-million), plus its more than 50 proprietary and patented compounds to fight inflammatory diseases. Mr. Fagan refers subscribers to Inflazyme's Nov. 8, 1999, news release for a full review of the company's affairs. canada-stockwatch.com For 2 weeks anyone can sign up for a free sub to the Fagan Report and a bunch others SO look at the TOP of the LIST and make sure that you check the box for the Fagan Report, and get the ATNA info who sponsers the gift, I like The Wolf Deposite there at Atna. faganreport.com Chucka